AusCann Group Holdings Ltd (AC8.AX)
| Previous close | 0.1050 |
| Open | 0.1050 |
| Bid | 0.1050 x 686300 |
| Ask | 0.1100 x 26372000 |
| Day's range | 0.1050 - 0.1100 |
| 52-week range | 0.0930 - 0.3000 |
| Volume | 89,191 |
| Avg. volume | 801,969 |
| Market cap | 48.46M |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0260 |
| Earnings date | 24 Aug 2021 - 30 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 19 Sept 2005 |
| 1y target est | N/A |
- PR Newswire
AusCann Commences Australian Product Registration with First Regulatory Filing for DermaCann®
AusCann Group Holdings Limited (ASX:AC8) ('AusCann' or 'the Company') is pleased to announce that it has submitted its first module to the Australian Pesticides and Veterinary Medicines Association (APVMA) to commence the submission of its dossier for the registration of DermaCann®, in development for anti-inflammatory and immune support in dogs with dermatological conditions.
- ABN Newswire
AusCann Group Holdings Ltd (AC8.AX) and CannPal Enter Into Scheme of Arrangement
AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.
- Simply Wall St.
Is AusCann Group Holdings (ASX:AC8) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
